Download PDF
Thromb Haemost 2006; 95(04): 593-599
DOI: 10.1160/TH05-05-0379
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France

Description of 62 novel mutations
Christine Vinciguerra
1   Laboratoire d’hémostase, Hopital Edouard Herriot, Lyon, France
2   EA 3735, Université Claude Bernard, Lyon I, France
,
Christophe Zawadzki
3   Laboratoire d’hématologie, Inserm ERI9, EA2693, Université Lille II, CHRU Lille, France
,
Yesim Dargaud
1   Laboratoire d’hémostase, Hopital Edouard Herriot, Lyon, France
,
Gilles Pernod
4   Laboratoire d’hématologie, Centre Hospitalo-Universitaire de Grenoble, France
,
Claire Berger
5   Service de pédiatrie, Centre Hospitalo-Universitaire de St. Etienne, France
,
Christophe Nougier
1   Laboratoire d’hémostase, Hopital Edouard Herriot, Lyon, France
,
Claude Négrier
1   Laboratoire d’hémostase, Hopital Edouard Herriot, Lyon, France
2   EA 3735, Université Claude Bernard, Lyon I, France
6   Centre régional de traitement de l’hémophilie, Hopital Edouard Herriot, Lyon, France
› Author AffiliationsFinancial support: This work was supported by grants from Ministère de la Santé (PHRC), Hospices Civils de Lyon, INSERM and Wyeth-Genetics Institute.
Further Information

Publication History

Received 31 May 2005

Accepted after revision 24 January 2006

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

Summary

Direct sequencing of the coding region of factor VIII (F8) gene was used to determine the mutations responsible for severe haemophilia A (FVIII<1%) in 128 unrelated haemophiliacs A, negative for intron 22 and intron 1 inversions. A mutation was found in 122/128 patients (95%). Ninety-six distinct mutations were identified in this cohort, 62 of these are novel. They consisted of deletions (7 large and 24 small deletions), insertions (n=9), associations of insertion/deletion (n=2), association of deletion/substitution (n=1), and single nucleotide substitutions (53 point mutations consisting of 31 missense, 20 nonsense, and 2 splicing mutations). Twenty-two patients had developed inhibitors, and among this subgroup 3 large deletions, 6 frameshift, 9 nonsense and 4 missense mutations were detected. For6 patients, among which one developed an anti-FVIII inhibitor, no mutations were detected in the coding and splicing regions of factor VIII gene. Different approaches of molecular modelling were performed in addition to familial linkage analysis to determine the pathophysiological responsibility of these novel missense mutations.

Keywords

Haemophilia A/B - gene mutations - inherited coagulation disorders
 

  • References

  • 1 Gitschier J, Wood WI, Goralka TM. et al. Characterization of the human factor VIII gene. Nature 1984; 312: 326-30.
    CrossrefPubMedGoogle Scholar
  • 2 Lakich D, Kazazian Jr HH, Antonarakis SE. et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophiliaA. Nat Genet 1993; 5: 236-41.
    CrossrefPubMedGoogle Scholar
  • 3 Antonarakis SE, Rossiter JP, Young M. et al. Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood 1995; 86: 2206-12.
    PubMedGoogle Scholar
  • 4 Bagnall RD, Waseem N, Green PM. et al. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 2002; 99: 168-74.
    CrossrefPubMedGoogle Scholar
  • 5 Riccardi F, Tagliaferri A, Manotti C. et al. Intron 1 factor VIII gene inversion in a population of Italian hemophilia A patients. Blood 2002; 100: 3432.
    CrossrefPubMedGoogle Scholar
  • 6 Kemball-Cook G, Tuddenham EG, Wacey AI. The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4. Nucleic Acids Res 1998; 26: 216-9.
    CrossrefPubMedGoogle Scholar
  • 7 Sambrook J, Fritsch EF, Maniatis T. In: Molecular cloning. Cold Spring Harbour Laboratory Press; New York USA: 1989. 2 9.16-9.19.
    Google Scholar
  • 8 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
    CrossrefPubMedGoogle Scholar
  • 9 Pemberton S, Lindley P, Zaitsev V. et al. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood 1997; 89: 2413-21.
    PubMedGoogle Scholar
  • 10 Pratt KP, Shen BW, Takeshima K. et al. Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 1999; 402: 439-42.
    CrossrefPubMedGoogle Scholar
  • 11 Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-23.
    CrossrefPubMedGoogle Scholar
  • 12 Antonarakis SE and the Nomenclature Working Group Recommendations for a nomenclature system for human gene mutations. Hum Mutat 1998; 11: 1-3.
    CrossrefPubMed
  • 13 Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Human Genet 1992; 90: 41-54.
    PubMedGoogle Scholar
  • 14 Kunkel TA, Alexander PS. The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation. J Biol Chem 1986; 261: 160-6.
    PubMedGoogle Scholar
  • 15 Oldenburg J. Mutation profiling in haemophilia A. Thromb Haemost 2001; 85: 577-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Attali O, Vinciguerra C, Trzeciak MC. et al. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations. Thromb Haemost 1999; 82: 1437-42.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Oldenburg J, Ivaskevicius V, Rost S. et al. Evaluation of DHPLC in the analysis of hemophilia A. J Biochem Biophys Methods 2001; 47: 39-51.
    CrossrefPubMedGoogle Scholar
  • 18 Frusconi S, Passerini I, Girolami F. et al. Identification of seven novel mutations of F8C by DHPLC. Hum Mutat 2002; 20: 231-2.
    PubMedGoogle Scholar
  • 19 Bicocchi MP, Pasino M, Lanza T. et al. Analysis of 18 novel mutations in the factor VIII gene. Br J Haematol 2003; 122: 810-7.
    CrossrefPubMedGoogle Scholar
  • 20 Bogdanova N, Markoff A, Pollmann H. et al. Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A. Hum Mutat 2002; 20: 236-7.
    PubMedGoogle Scholar
  • 21 Amano K, Sarkar R, Pemberton S. et al. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII. Blood 1998; 91: 538-48.
    PubMedGoogle Scholar
  • 22 Saenko EL, Shima M, Rajalakshmi KJ. et al. A role for the C2 domain of factor VIII in binding to von Willebrand factor. J Biol Chem 1994; 269: 11601-5.
    PubMedGoogle Scholar
  • 23 Barrow RT, Healey JF, Jacquemin MG. et al. Antigenicity of putative phospholipid membrane-binding residues in factor VIII. Blood 2001; 97: 169-74.
    CrossrefPubMedGoogle Scholar
  • 24 Ivaskevicius V, Jurgutis R, Rost S. et al. Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data. Br J Haematol 2001; 112: 1062-70.
    CrossrefPubMedGoogle Scholar
  • 25 Vidal F, Farssac E, Altisent C. et al. Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: identification of 14 novel mutations. Thromb Haemost 2001; 85: 580-3.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Klopp N, Oldenburg J, Uen C. et al. 11 hemophilia A patients without mutations in the factor VIII encoding gene. Thromb Haemost 2002; 88: 357-60.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 El-Maarri O, Herbiniaux U, Graw J. et al. Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. J Thromb Haemost 2005; 3: 332-9.
    CrossrefPubMedGoogle Scholar
  • 28 Goodeve AC, Williams I, Bray GL. et al. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group. Thromb Haemost 2000; 83: 844-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia 2002; 8 (Suppl. 02) 23-9.
    CrossrefPubMedGoogle Scholar
  • 30 David D, Santos IM, Johnson K. et al. Analysis of the consequences of premature termination codons within factor VIII coding sequences. J Thromb Haemost 2003; 1: 139-46.
    CrossrefPubMedGoogle Scholar
  • 31 Young M, Inaba H, Hoyer LW. et al. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. AmJ Hum Genet 1997; 60: 565-73.
    PubMedGoogle Scholar
  • 32 Wakabayashi H, Freas J, Zhou Q. et al. Residues 110-126 in the A1 domain of factor-VIII containa Ca2+ binding site required for cofactor activity. J Biol Chem 2004; 279: 12677-84.
    CrossrefPubMedGoogle Scholar
  • 33 Pipe SW, Saenko AL, Eickhorst AN. et al. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIII. Blood 2001; 97: 685-91.
    CrossrefPubMedGoogle Scholar